Opinion: The big winner from pharmacare? Canadian business

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 92%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

The big winner from pharmacare? Canadian business

pay for things such as better public transit and more support for the poor; the United States’s much lower taxes means they can’t afford European-style social programs.Some readers e-mailed and said, hang on Keller, what about innovation? What about efficiency? A well-run organization – business or government – can deliver more bang for the buck. Leadership matters. Management matters. Plans matter. Successful organizations plan to get the most from every dollar.

Prescription drug spending in Canada was nearly $39-billion last year, according to the Canadian Institute for Health Information. More than $14-billion of that came from private insurance, nearly all of which is workplace insurance. Under publicly funded pharmacare, those cost to business would largely disappear., per employee, according to the 2019 report from the advisory council on pharmacare, headed by Dr.

As a result, the provinces are paying a big chunk of Canada’s drug costs: nearly 40 per cent of drug spending in Alberta and British Columbia, 48 per cent in Ontario and Quebec, and 51 per cent in Saskatchewan, according to the Hoskins report. But since drugs aren’t part of medicare, Ottawa’s financial support is minimal.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 5. in RU

Россия Последние новости, Россия Последние новости